Riskpilot← Back to searchSign inGet full accessINSPEKT MOLAB AS
ASActiveOrg 932298147Ytterøra 25, 8656 MosjøenTechnical testing and analysis · NACE 7120Est. 202313 employees
Revenue 2024
NOK 11,8M
EBITDA margin
4.2%
+24852250% vs 2023
Equity ratio
10.4%
Financial strength
Net profit 2024
NOK 96K
+7696% vs 2023
| Revenue | NOK 11,8M | — |
| EBITDA | NOK 497K | +24852250% |
| Net profit | NOK 96K | +7696% |
| Total assets | NOK 6,8M | +26470% |
| Equity | NOK 707K | +2658% |
| Employees | 13 | — |
Legal name
INSPEKT MOLAB AS
Org number
932298147
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
26. oktober 2023
Share capital
NOK 30 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utføre destruktiv testing og labratorievirksomhet, ikke-ødeleggende testing ndt, kvalitetssikring, kontroll og inspeksjonstjenester samt mekaniske og tekniske konsulenttjenester som er relatert til dette, og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Ytterøra 25, 8656 Mosjøen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 11 782 |
| Staff expenses | −0 | −6 951 |
| EBITDA | −0 | 497 |
| Depreciation & amort. | −0 | −451 |
| EBIT | −0 | 46 |
| Net financials | 0 | −48 |
| Profit before tax | −0 | −2 |
| Tax | −1 | −98 |
| Net profit | 1 | 96 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 26 | 6 817 |
| Equity | 26 | 707 |
| Long-term debt | 0 | 464 |
| Short-term debt | 0 | 5 645 |
| Total debt | 0 | 6 109 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20232024
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20232024
Return on equity
13.5%
This company
18.4%
Market median
+27% vs market
20232024
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20232024
Asset turnover
1.73×
This company
1.12×
Market median
+54% vs market
20232024
Debt / equity
8.64×
This company
0.62×
Market median
-1294% vs market
20232024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
WA Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Testpartner Invest As | Company | 100.0% | 100.0% | 2024 |
Testpartner As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gregerodden As
INSPEKT MOLAB AS Board members of INSPEKT MOLAB AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robert Myrvang | Chief Executive Officer | 0 companies |
| William Andreas Rise | Chief Executive Officer | 0 companies |
| Torstein Aasen | Board of Directors | 0 companies |
| Bjørnar Meland | Board of Directors | 0 companies |
| Johan Olov Håkan Renhorn | Board of Directors | 0 companies |
| Bengt Niklas Persson | Chairman | 0 companies |
| Lars André Sivertsen Tverå | Board of Directors | 0 companies |